Hikma Pharmaceutical reported $3.63B in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Almirall ALM:SM EUR 1.92B 152.39M
Argen X Bv ARGX:BB USD 19.27B 1.02B
AstraZeneca AZN:LN USD 173.83B 19.74B
Bayer BAYN:GR EUR 47.48B 894.01M
Fresenius FRE:GR EUR 14.73B 2.37B
Fresenius Medical Care FMS:US EUR 9.56B 1.22B
Galapagos GLPG:NA EUR 2.72B 169.2M
Genmab GEN:DC DKK 193.99B 31.99B
GlaxoSmithKline GSK:LN GBP 58.86B 5.75B
Hikma Pharmaceutical HIK:LN USD 3.42B 142.28M
Lonza Group LONN:SW CHF 33.74B 4.16B
Merck MRK:GR EUR 23.29B 1.73B
Orion ORNBV:FH EUR 7.23B 1.14B
Recordati REC:IM EUR 7.88B 798.86M
Roche Holding ROG:VX CHF 242.39B 20.72B
Sanofi SAN:FP EUR 113.87B 14.5B
UCB UCB:BB EUR 15.68B 3.83B